Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors find better ways to treat cancer.
PURPOSE: This laboratory study is looking into genes in samples from younger patients with relapsed acute lymphoblastic leukemia.
Genetic: RNA analysis
Genetic: gene expression analysis
Genetic: microarray analysis
Genetic: nucleic acid sequencing
Genetic: polymerase chain reaction
Other: laboratory biomarker analysis
|Official Title:||Molecular Taxonomy of Pediatric Cancer|
- Cellular origins of relapse and the underlying epigenetic mechanisms associated with drug resistance [ Designated as safety issue: No ]
|Study Start Date:||June 2012|
|Estimated Primary Completion Date:||August 2012 (Final data collection date for primary outcome measure)|
- To identify global changes in the epigenome and various underlying histone modifications that characterize relapsed acute lymphoblastic leukemia (ALL).
- To identify specific transcription factor-binding sites associated with histone alterations.
- To correlate gene expression changes of differentially regulated genes at relapse with underlying chromatin modifications.
OUTLINE: Archived bone marrow samples, collected at the time of diagnosis and relapse, are analyzed for gene expression and histone modifications by microarray, chromatin immunoprecipitation (ChIP) sequencing, and quantitative real-time polymerase chain reaction (qRT-PCR).
|Principal Investigator:||William L. Carroll, MD||NYU Clinical Cancer Center|